Three biosimilar drugs — approved versions of brand-name therapies that have no clinically meaningful differences compared with their reference products — including one for multiple sclerosis (MS), will soon be […]
The post New partnership bringing MS biosimilar drug to MENA region appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com